Skip to main content

Table 4 Pharmacological properties and therapeutic targets of GA and Myr

From: Effect of Gallic acid and Myricetin on ovarian cancer models: a possible alternative antitumoral treatment

  1. LD50 median lethal dose, MRDD maximum recommended daily dose, ADME absorption distribution metabolism and excretion, hERG human ether-a-go-go-related gene, SP Swiss-Prot protein sequence database (UniProt)
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us